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Abstract
Inorganic sulfate is essential for normal cellular function and its homeostasis
is primarily regulated in the kidneys. However, little is known about renal sul-
fate handling in humans and particularly in populations with impaired kidney
function such as renal transplant recipients (RTR). Hence, we aimed to assess
sulfate reabsorption in kidney donors and RTR. Plasma and urinary sulfate
were determined in 671 RTR and in 251 kidney donors. Tubular sulfate reab-
sorption (TSR) was defined as filtered load minus sulfate excretion and frac-
tional sulfate reabsorption (FSR) was defined as 1-fractional excretion. Linear
regression analyses were employed to explore associations of FSR with baseline
parameters and to identify the determinants of FSR in RTR. Compared to
kidney donors, RTR had significantly lower TSR (15.2 [11.2–19.5] vs. 20.3
[16.7–26.3] lmol/min), and lower FSR (0.56 [0.48–0.64] vs. 0.64 [0.57–0.69])
(all P < 0.001). Kidney donation reduced both TSR and FSR by circa 50%
and 25% respectively (both P < 0.001). In RTR and donors, both TSR and
FSR associated positively with renal function. In RTR, FSR was independently
associated with urinary thiosulfate (b = 0.18; P = 0.002), growth hormone
(b = 0.12; P = 0.007), the intakes of alcohol (b = 0.14; P = 0.002),
methionine (b = 0.34; P < 0.001), cysteine (b = 0.41; P < 0.001), and
vitamin D (b = 0.14; P = 0.009). In conclusion, TSR and FSR are lower in
RTR compared to kidney donors and both associated with renal function.
Additionally, FSR is determined by various dietary and metabolic factors.
Future research should determine the mechanisms behind sulfate handling in
humans and the prognostic value of renal sulfate reabsorption in RTR.
Introduction
Inorganic sulfate is the fourth most abundant anion in
human plasma, and its concentration is primarily deter-
mined by renal excretion and reabsorption (Goudsmit
et al. 1939; Hierholzer et al. 1960). The indispensable role
of sulfate in normal cell function is reflected by its
involvement in a wide variety of physiological processes,
such as biosynthesis of proteoglycans, activation of
endogenous compounds, for example, heparin, gastrin,
and cholecystokinin, and metabolism and detoxification
of various endogenous substances and xenobiotics (Falany
1997; Cole and Evrovski 2000; Lee et al. 2000; Dawson
et al. 2003, 2015; Markovich and Aronson 2007). While
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the key regulatory processes of renal sulfate handling have
been extensively studied in animals and cell lines (Renfro
and Dickman 1980; Leyh et al. 1992; Cherest et al. 1997;
Smith et al. 2000), very little is known about these mech-
anisms in humans. In 1960, a study that measured sulfate
reabsorption in 16 healthy adults before and after infu-
sion of sodium sulfate (Becker et al. 1960), showed that
tubular sulfate reabsorption was saturable and varied
markedly between individuals. However, the effect of
renal function on renal sulfate reabsorption remains, to
date, unknown. Additionally, factors that have been
shown to influence tubular sulfate reabsorption in ani-
mals and cell lines, for example, growth hormones, thy-
roid hormone, and nonhormonal factors, for example,
dietary sulfate, vitamin, and NSAID intake, have not been
assessed in humans (Sabry et al. 1965; Frick and Durasin
1986; Neiberger 1991; Tenenhouse et al. 1991; Fernandes
et al. 1997; Sagawa et al. 1998a,b, 1999a,b; Markovich
et al. 1999).
To investigate sulfate reabsorption in humans, we mea-
sured sulfate reabsorption in kidney donors, before and
after donation and in a well-characterized cohort with a
large variation in renal function, that is, renal transplant
recipients (RTR), allowing us to (1) assess and compare
sulfate reabsorption in kidney donors before donations
and RTR, (2) investigate the influence of kidney donation
on sulfate reabsorption in kidney donors, (3) determine
the influence of renal function on sulfate reabsorption in
kidney donors and RTR, and (4) identify the determi-
nants of sulfate reabsorption in RTR.
Materials and Methods
Study population
This cross-sectional study was based on a previously
described, well-characterized set of 707 RTR (van den
Berg et al. 2012, 2014.) In brief, this cohort included RTR
(aged ≥ 18 years) who visited the outpatient clinic of the
University Medical Center Groningen (UMCG), Gronin-
gen, the Netherlands, between November 2008 and June
2011 and who had a graft that had been functioning for
at least 1 year with no history of alcohol and/or drug
addiction. We excluded subjects with missing data on
tubular sulfate reabsorption (TSR) and fractional sulfate
reabsorption (FSR), that is, 36 cases, from the statistical
analyses, which resulted in 671 cases eligible for analyses.
As a control group, we included 251 healthy kidney
donors of whom biomaterial was collected before and
after kidney donation, with 3 months between collections.
The study protocol was approved by the UMCG institu-
tional review board (METc 2008/186) and adhered to the
Declarations of Helsinki.
Data collection and measurements
Information on dietary intake was obtained from a vali-
dated semi-quantitative food frequency questionnaire,
which was developed at Wageningen University to assess
nutrient intake (Eisenga et al. 2016). Because not all par-
ticipants completed or returned the FFQ, only 643 of the
671 RTR had data available on dietary intake derived
from the FFQ, (whereas 671 RTR had plasma sulfate con-
centrations, TSR and FSR available). The FFQ inquired
about intake of 177 food items during the last month,
taking seasonal variations into account. For each item,
the frequency was recorded in times per day, week, or
month. The number of servings was expressed in natural
units (e.g., slice of bread or apple) or household measures
(e.g., cup or spoon). The questionnaire was self-adminis-
tered and filled out at home. All FFQs were checked for
completeness by a trained researcher, and inconsistent
answers were verified with the patients. Validation of the
FFQ in RTR was assessed as previously reported (Oste
et al. 2017). Dietary data were converted into daily nutri-
ent intake using the Dutch Food Composition Table of
2006 (National Institute for Public Health and the Envi-
ronment, 2013.) Medication use was determined using
patients’ medical records.
Participants were asked to collect a 24-h urine sample
on the day prior to visiting the outpatient clinic. Urine
was collected under oil, and chlorhexidine was added as
an antiseptic agent. Urinary protein concentration was
determined by means of the Biuret reaction (MEGA AU
510; Merck Diagnostica, Darmstadt, Germany). Protein-
uria was defined as urinary protein excretion ≥0.5 g/24 h.
Upon completion of the 24-h urine collection, fasting
blood samples were obtained the following morning, and
venous blood samples were analyzed spectrophotometri-
cally immediately thereafter. Plasma sulfate and urinary
sulfate were measured by means of a validated ion-
exchange chromatography assay with conductivity detec-
tion (Metrohm, Herisau, Switzerland). Growth hormone
was assessed with a high sensitivity chemiluminescence
sandwich immunoassay (SphingoTec GmbH, Borgsdorf,
Germany), as described elsewhere (Hallengren et al.
2014). Other laboratory measurements were performed
with automated and validated routine methods (Roche
Diagnostics, Basel, Switzerland). Diabetes (mellitus) was
diagnosed according to American Diabetes Association
criteria as fasting plasma glucose concentration of at least
7.0 mmol/L or use of antidiabetic medication. (Abbasi
et al. 2012)
TSR was calculated to align results of our current anal-
yses with existing literature in the field of sulfate reab-
sorption dating from 1960 (Becker et al. 1960), where
data for TSR were presented. TSR was expressed as
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absolute tubular sulfate reabsorption and was defined as
the filtered load minus the sulfate excretion, calculated as:
TSR ðlmol/minÞ ¼ PSO4 GFRUSO4V
where USO4 and PSO4 represent urinary and plasma con-
centrations of sulfate in µmol/mL; GFR represents
glomerular filtration rate in mL/min; and V represents
urine flow in mL/min.
Measures of tubular reabsorption, including TSR, typi-
cally depend strongly on renal function. Therefore, it is
currently more common to correct for renal function,
using the fractional reabsorption, that is, FSR in case of
sulfate. FSR was defined as the TSR divided by the filtered
load and was calculated as follows:
FSR ð%Þ ¼ TSR=ðGFRPSO4Þ100
When GFR is approximated by creatinine clearance,
FSR mathematically corresponds to 1 minus the fractional
sulfate excretion, calculated as follows:
FSR ¼ ½1 ðUSO4 PcreatÞ=ðPSO4UcreatÞ100%
where Pcreat and Ucreat represents urinary and plasma con-
centrations of creatinine in µmol/mL. In RTR, TSR and
FSR were assessed using GFR based on creatinine clear-
ance, since no 125I-Iodothalamate data were available for
RTR. In kidney donors, TSR and FSR were assessed twice,
that is, using GFR based on creatinine clearance for com-
parison with RTR, and using GFR assessed by the urinary
clearance of 125I-Iothalamate method for comparing pre-
and post-donation parameters. For assessment of the
associations with renal function, TSR and FSR were calcu-
lated using creatinine clearance in RTR and 125I-Iothala-
mate in kidney donors.
Statistical analyses
Data analysis was performed using SPSS 22.0 for Win-
dows (SPSS Inc., Chicago, IL), GraphPad Prism version
5.01 for Windows (GraphPad Software, San Diego, CA),
and R version 3.2.3 (The R-Foundation for Statistical
Computing, Vienna, Austria). In R, generalized additive
models of the mgcv package were used to model the asso-
ciations of plasma sulfate with TSR and FSR. Model effect
and nonlinearity were tested by two-sided Wald tests.
Pnonlinearity was calculated by comparing restricted cubic
spline terms to a linear model.
Data are presented as mean  standard deviation (SD)
for normally distributed data, as median [interquartile
range (IQR)] for non-normally distributed data, and as
number (percentage) for nominal data. A two-sided
P < 0.05 was considered to indicate statistical signifi-
cance.
Differences between RTR and kidney donors in plasma
sulfate, TSR and FSR were tested using linear regression
analysis. This type of analysis was also employed to
investigate cross-sectional associations of FSR with base-
line variables (Ptrend). Mann–Whitney U test and inde-
pendent t-test were used to assess the differences in
sulfate parameters before and after donation in kidney
donors.
Associations of TSR and FSR with renal function
parameters were tested using linear regression analysis.
Additional adjustments were made for age and gender.
To check for interaction between age and renal function,
and gender and renal function, interaction terms were
calculated and checked for significance in a linear regres-
sion model with TSR and FSR, separately.
Since TSR depends more on renal function than FSR,
FSR was used for determinant analysis. Determinants of
FSR were identified in a multivariable regression model,
in which variables that were suggested to affect FSR in
animals and cell lines, were included. These variables
included plasma sulfate, thiosulfate excretion, intake of
alcohol, water, bread, fruit, methionine, cysteine, vitamin
D, use of NSAID, serum potassium, venous pH, venous
HCO3
, net acid excretion, thyroid hormones and growth
hormone. In the multivariable models, adjustments were
made for common confounders such as age, gender,
smoking, BMI, proteinuria, total energy intake, and pri-
mary renal disease.
To check for interaction between age and growth
hormone, and gender and growth hormone, interac-
tion terms were calculated and checked for significance
in a linear regression model with TSR and FSR,
separately.
Results
Sulfate reabsorption in RTR and kidney
donors before donation
Mean age of RTR at inclusion (5.3 (1.8–12.1) years
after transplantation) was 53  13 years and 57% were
male, compared to 54  11 years and 47% males for
kidney donors, respectively. Differences in plasma
sulfate, TSR and FSR between kidney donors and RTR
are displayed Figure 1. Median plasma sulfate [in-
terquartile range (IQR)] in kidney donors was 0.28
[0.24–0.31] mmol/L, compared to 0.43 [0.35–0.54]
mmol/L in RTR (P < 0.001). Kidney donors had higher
TSR than RTR, 20.3 [16.7–26.3] µmol/min versus 15.2
[11.2–19.5], (P < 0.001), respectively. Furthermore,
kidney donors also had higher FSR than RTR,
0.64 [0.57–0.69] versus 0.56 [0.48–0.64] (P < 0.001),
respectively.
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
2018 | Vol. 6 | Iss. 8 | e13670
Page 3
A. Post et al. Renal Sulfate Handling in Humans
Sulfate reabsorption before and after
kidney donation in kidney donors
Sulfate parameters in kidney donors, before and after
donation, are shown in Table 1. Kidney donation caused
a reduction in renal function (113  22 to 74  13;
P < 0.001) and sulfate excretion in kidney donors (17.7
[14.4–20.8] vs. 17.2 [12.2–22.0]; P < 0.001). Furthermore,
after kidney donation, plasma sulfate concentration
increased significantly (0.27 [0.24–0.31] vs. 0.29 [0.26–
0.32]; P < 0.001), while TSR (18.8  6.3 vs. 9.3  4.5;
P < 0.001) and FSR (60 [54–67] vs. 45 [32–53];
P < 0.001) were reduced, Figure 2.
Sulfate reabsorption and renal function in
kidney donors and RTR
In kidney donors before donation, mGFR was 111 [98–
128] mL/min/1.73 m2. TSR (b = 0.50; P < 0.001), but
not FSR (b = 0.11; P = 0.099) was associated with mGFR
in the crude model. After adjustment for age and gender,
both TSR (b = 0.65; P < 0.001) and FSR (b = 0.25;
P = 0.003) associated with mGFR. No significant interac-
tion between gender and mGFR, nor age and mGFR was
found, in the associations with TSR and FSR respectively.
In RTR, the creatinine clearance was 64 [46–83] mL/





































































Figure 1. Plasma sulfate concentrations, tubular sulfate reabsorption and fractional sulfate reabsorption in 251 kidney donors before kidney
donation and in 671 renal transplant recipients. RTR, renal transplant recipients.
Table 1. Sulfate parameters in kidney donors before and after kidney donation.
Pre-donation Post-donation P for difference
Plasma sulfate (mmol/L) 0.27 [0.24–0.31] 0.29 [0.26–0.32] <0.001
Sulfate excretion (mmol/24 h) 17.7 [14.4–20.8] 17.2 [12.2–22.0] <0.001
GFR (mL/min/1.73 m2) 113  22 74  13 <0.001
Sulfate clearance (mL/min) 43.9 [35.9–53.4] 39.3 [31.2–50.2] <0.001
Fractional sulfate excretion (%) 40 [33–46] 55 [47–68] <0.001
Filtered sulfate load (lmol/min) 30.3 [26.3–36.0] 22.1 [189–25.0] <0.001
Tubular sulfate reabsorption (lmol/min) 18.8  6.3 9.3  4.5 <0.001
Fractional sulfate reabsorption (%) 60 [54–67] 45 [32–53] <0.001
Tubular potassium reabsorption (lmol/min) 361 [314–437] 231 [201–272] <0.001
Fractional potassium reabsorption (%) 0.86 [0.83–0.89] 0.80 [0.76–0.84] <0.001
Tubular sodium reabsorption (mmol/min) 15.7 [13.8–18.0] 10.2 [9.0–11.6] <0.001
Fractional sodium reabsorption (%) 0.99 [0.99–0.99] 0.99 [0.99–0.99] <0.001
P value for difference was tested by Wilcoxon Signed-Rank test or paired sample t-test. Tubular and fractional sulfate reabsorption were calcu-
lated using the urinary clearance of 125I-iothalamate method as the measured GFR.
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P = 0.019) was associated with creatinine clearance in the
crude model. After adjustment for age and gender, TSR
(b = 0.57; P < 0.001) and FSR (b = 0.13; P = 0.001) this
association remained significant. No significant interac-
tion between gender and creatinine clearance, nor age
and creatinine clearance was found, in the associations
with TSR and FSR, respectively.
Baseline characteristics in RTR
Baseline characteristics of the total RTR cohort and
according to tertiles of FSR are shown in Table 2. FSR
was positively associated with age, BMI, deceased kidney
donor (verses living donor), hs-CRP, NT-proBNP, use of
antihypertensives and diuretics, and growth hormone (all
P < 0.05). Inverse associations were observed between
FSR and sulfate excretion, thiosulfate excretion, male gen-
der, intake of alcohol, water, bread, fruit, animal protein,
the sulfur-containing amino acids methionine and cys-
teine, vitamin D, and energy, as well as with renovascular
disease, serum creatinine and net acid excretion (all
P < 0.05). Additionally, we observed a positive nonlinear
association between plasma sulfate and TSR and FSR, as
represented by Figure 3.
Potential determinants of FSR
For relevant hormonal and nonhormonal parameters,
their associations with FSR are shown in Table 3. In the
multivariable linear regression model, FSR was positively
associated with growth hormone (b = 0.12; P = 0.007)
and inversely associated with urinary thiosulfate
(b = 0.18; P = 0.002), net acid excretion (b = 0.19;
P < 0.001), intakes of alcohol (b = 0.14; P = 0.002),
water (b = 0.15; P = 0.003), bread (b = 0.12;
P = 0.010), vegetable (b = 0.12; P = 0.005), methionine
(b = 0.34; P < 0.001), cysteine (b = 0.41; P < 0.001)
and vitamin D (b = 0.14; P = 0.009). No associations
were found between FSR and venous pH, serum potas-
sium, thyroid hormones, and NSAID use (P≥0.05).
In the association with FSR, significant interaction was
found between gender and growth hormone. After split-
ting on gender, FSR associated positively with growth
hormone (b = 0.21; P < 0.001) in men, while no associa-
tion was present in women (b = 0.04; P = 0.599).
Discussion
To the best of our knowledge, this is the first study that
comprehensively assessed plasma sulfate concentrations
and sulfate reabsorption in healthy individuals and stable
RTR. Compared to kidney donors, plasma sulfate concen-
trations in RTR were significantly higher, while TSR and
FSR were significantly lower. In kidney donors, kidney
donation increased plasma sulfate and reduced both TSR
and FSR. Furthermore, in both RTR and kidney donors
TSR and FSR were found to associate with renal function.
In addition, we confirmed some, but not all, of the hor-
monal and non-hormonal factors known to affect renal
sulfate reabsorption in animal and in vitro studies, as
determinants of sulfate reabsorption in RTR.
In humans, most of the inorganic sulfate in the circula-
tion is generated from the sulfur containing amino acids
methionine and cysteine, which are derived from dietary
protein (Sabry et al. 1965; Grimble 1994; Houterman
et al. 1997). Circulating inorganic sulfate concentrations
in plasma are primarily regulated by the kidneys, which
filter and extensively reabsorb the cleared sulfate to






















































Figure 2. Tubular and fractional sulfate reabsorption before and after kidney donation in 251 kidney donors. Tubular and fractional sulfate
reabsorption were calculated using the urinary clearance of 125I-Iothalamate method as GFR.
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Table 2. Baseline characteristics of renal transplant recipients presented according to gender-stratified tertiles of fractional sulfate reabsorp-
tion.




0.04–0.54 (N = 222)
II
0.49–0.76 (N = 225)
III
0.61–0.84 (N = 224)
FSR, % 0.56  0.12 0.42  0.09 0.57  0.04 0.68  0.05
Urinary sulfate, mmol/24 h 17.6  6.4 20.8  6.4 17.9  5.4 14.0  4.8 <0.001
Urinary thiosulfate, lmol/24 h 7.1 [4.0–12.0] 8.6 [4.4–13.2] 7.9 [4.3–13.3] 5.9 [3.5–9.3] <0.001
Demographics
Age, years 53  13 52  13 53  13 54  13 0.02
Male gender, n (%) 384 (57) 128 (57) 128 (57) 128 (57)
BMI, kg/m2 26.0 [23.3–29.3] 25.6 [23.1–28.7] 26.0 [23.6–29.2] 26.5 [23.2–30.1] 0.003
Smokers, n (%)
Never 266 (42) 84 (39) 88 (42) 94 (45) 0.22
Past 285 (45) 102 (48) 101 (49) 82 (39) 0.09
Current 77 (12) 25 (12) 19 (9) 33 (16) 0.45
Dialysis vintage, months 24 [10–47] 24 [9–50] 23 [8–46] 25 [14–50] 0.08
Time since Rtx, years 5.4 [1.8–12.0] 5.0 [1.3–11.3] 6.1 [1.4–12.0] 5.7 [2.9–12.9] 0.06
Deceased donor, n (%) 433 (66) 130 (60) 142 (64) 161 (72) 0.003
Creatinine excretion, mmol/24 h 11.3 [9.2–14.0] 11.5 [9.2–14.3] 11.7 [9.6–14.1] 11.0 [8.9–13.9] 0.05
Dietary intake
Vegetarian, n (%) 14 (2) 5 (2) 5 (3) 4 (2) 0.68
Alcohol intake, g/d 3.0 [0.04–11.5] 4.6 [0.1–14.8] 3.4 [0.2–12.5] 1.0 [0.02–8.5] <0.001
Water intake, g/d 2074  587 2138  599 2093  559 2021  719 0.002
Bread intake, g/d 133  60 137  65 132  53 129  62 <0.001
Fruit, g/d 123 [60–232] 135 [73–239] 124 [66–237] 105 [50–227] 0.04
Vegetables, g/d 91 [51–123] 91 [58–132] 91 [56–1234] 85 [46–116] 0.35
Animal protein, g/d 53  16 53  16 52  14 49  15 0.001
Vegetable protein, g/d 31  10 31  11 30  8 30  11 0.07
Methionine, mg/d 1884  5.9 1923  495 1895  421 1795  496 <0.001
Cysteine, mg/d 1190  307 1220  313 1191  249 1145  312 <0.001
Vitamin D intake, lg/d 4.6 [3.4–5.9] 4.7 [3.4–6.0] 4.7 [3.7–5.8] 4.4 [3.3–5.9] 0.001
Energy intake, kcal/d 2173  656 2174  635 2171  567 2159  687 0.02
Primary renal disease, n (%)
Primary glomeruloslerosis 192 (29) 59 (27) 68 (30) 65 (29) 0.52
Glomerulonephritis 51 (8) 15 (7) 18 (8) 18 (8) 0.54
Tubulointerstitial nephritis 77 (11) 25 (11) 23 (10) 29 (13) 0.26
Polycystic kidney disease 136 (20) 43 (19) 47 (21) 45 (20) 0.81
Hypo- or dysplasia 27 (4) 10 (5) 10 (4) 7 (3) 0.07
Renovascular disease 39 (6) 18 (8) 12 (5) 9 (4) 0.01
Glucose homeostasis
Diabetes, n (%) 163 (24) 46 (21) 53 (24) 64 (29) 0.03
Glucose, mmol/L 5.3 [4.8–6.0] 5.3 [4.8–6.0] 5.2 [4.7–5.9] 5.3 [4.8–6.2] 0.85
HbA1c, % 6.0  0.8 5.9  0.8 6.0  0.8 6.1  0.9 0.74
Antidiabetics, n (%) 105 (16) 30 (14) 34 (15) 41 (16) 0.09
Inflammation
hs-CRP, mg/L 1.6 [0.7–4.7] 1.5 [0.6–3.5] 1.7 [0.8–5.3] 1.7 [0.8–5.0] 0.01
Cardiovascular
NT-proBNP, ng/L 251 [104–612] 200 [98–615] 235 [95–515] 285 [119–703] <0.001
SBP, mmHg 136  17 135  18 135  16 137  18 0.40
DBP, mmHg 83  11 83  12 83  10 81  10 0.09
Antihypertensives, n (%) 592 (88) 188 (84) 198 (88) 205 (92) 0.04
Diuretic, n (%) 245 (36) 71 (32) 97 (43) 103 (46) <0.001
Potassium sparing 4 (1) 2 (1) 0 (0) 2 (1) 0.88
Loop 138 (21) 42 (19) 47 (21) 49 (22) 0.08
Thiazide 102 (15) 21 (9) 43 (19) 38 (17) 0.11
(Continued)
2018 | Vol. 6 | Iss. 8 | e13670
Page 6
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Renal Sulfate Handling in Humans A. Post et al.
maintain plasma sulfate concentrations between approxi-
mately 0.24 and 0.42 mmol/L (Goudsmit et al. 1939;
Hierholzer et al. 1960; Cole and Evrovski 1997; Kock
et al. 1997). Plasma sulfate concentrations in kidney
donors before donation are in line with these studies.
Compared to kidney donors before donation, plasma sul-
fate is higher in RTR, while TSR and FSR are both lower.
Higher plasma sulfate values are likely the consequence of
decreased kidney function (Hierholzer et al. 1960), while
the lower TSR and FSR values may either be attributed to
the use of corticosteroids in RTR, which are known to
down-regulate gene expression of the NaS1 transporter
(Renfro et al. 1989), or to reduced renal function, as seen
in the kidney donors after donation.
In the kidney donors, the plasma sulfate concentra-
tions increased after kidney donation, whereas TSR and
FSR decreased by approximately 50% and 25%, respec-
tively. Since sulfate is freely filtered, the increase in
plasma sulfate is to be expected after reduction in renal
function. The changes in TSR and FSR can be explained
by several mechanisms that underlie sulfate reabsorption.
The active process of sulfate reabsorption is regulated
by various transporters located in the proximal tubuli
(Brazy and Dennis 1981; Lucke et al. 1981; Pritchard
and Renfro 1983; Low et al. 1984; Schneider et al. 1984;
Turner 1984; Bastlein and Burckhardt 1986; Kuo and
Aronson 1988; Markovich and Aronson 2007). However,
the rate limiting step is thought to be mediated by the
apical sodium sulfate co-transporter (NaS1), which
works at a near maximal rate under physiological condi-
tions (Becker et al. 1960; Mudge et al. 1973). In view of
this, the circa 50% reduction in TSR can be explained
by the circa 50% reduction in total sodium-sulfate co-
transporters after kidney donation. When comparing the
changes in TSR with tubular reabsorption of potassium
and sodium it becomes clear that kidney donation has a
more profound effect on sulfate reabsorption than on
potassium and sodium reabsorption, further supporting
Table 2. Continued.




0.04–0.54 (N = 222)
II
0.49–0.76 (N = 225)
III
0.61–0.84 (N = 224)
Total cholesterol, mmol/L 5.1  1.1 5.1  1.1 5.2  1.1 5.1  1.2 0.65
HDL-cholesterol, mmol/L 1.4  0.5 1.4  0.5 1.4  0.5 1.4  0.5 0.94
LDL-cholesterol, mmol/L 2.9 [2.3–3.5] 2.9 [2.4–3.5] 3.0 [2.4–3.6] 2.8 [2.3–3.5] 0.54
Triglycerides, mmol/L 1.7 [1.2–2.3] 1.7 [1.2–2.2] 1.7 [1.2–2.3] 1.7 [1.3–2.4] 0.07
Statins, n (%) 350 (52) 112 (50) 117 (52) 121 (54) 0.34
NSAID, n (%) 127 (19) 40 (18) 45 (20) 42 (19) 0.74
Renal function
eGFR, mL/min/1.73 m2 45  19 44  18 47  19 45  18 0.59
Proteinuria, ≥0.5 g/24 h, n (%) 149 (22) 41 (18) 46 (21) 62 (28) 0.12
Metabolic parameters
Serum potassium, mmol/L 3.98  0.47 3.84  0.46 3.95  0.44 4.03  0.49 0.20
Venous pH 7.4  0.04 7.4  0.04 7.4  0.04 7.4  0.04 0.32
Venous HCO3
, mmol/L 24.7  3.1 24.5  2.9 24.9  3.1 24.6  3.2 0.83
Net acid excretion, mEq/24 h 61.1  32.6 63.6  34.8 63.0  27.9 56.2  33.8 <0.001
Liver function
LDH, U/L 198 [170–232] 200 [167–233] 197 [173–235] 197 [170–228] 0.42
Alkaline phosphatase, U/L 68 [54–84] 66 [54–80] 68 [54–85] 69 [54–88] 0.82
Gamma-GT, U/L 26 [19–41] 26 [19–43] 26 [19–39] 27 [19–42] 0.40
Endocrinology
Triiodothyronine, pmol/L 4.9  0.8 4.9  0.8 4.9  0.9 4.8  0.7 0.27
Thyroxine, pmol/L 16.1  2.9 16.2  2.6 16.2  3.0 15.8  3.2 0.24
Growth hormone, ng/mL 0.34 [0.10–1.07] 0.27 [0.08–1.01] 0.30 [0.09–0.87] 0.43 [0.12–1.28] 0.002
Immunosuppression
CNI, n (%) 382 (57) 121 (54) 127 (56) 134 (60) 0.05
Proliferation inhibitor, n (%) 560 (83) 188 (84) 192 (85) 179 (80) 0.37
Prednisolone, mg/24 h 10.0 [7.5–10.0] 10.0 [7.5–10.0] 10.0 [7.5–10.0] 10.0 [7.5–10.0] 0.36
RTR, renal transplant recipients; RSR, renal sulfate reabsorption, BMI, body mass index; Rtx, renal transplantation; hs-CRP, high-sensitive C-
reactive protein; NT-proBNP, N-terminal pro-b-type natriuretic peptide; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-
density lipoprotein; LDL, low-density lipoprotein; NSAID, nonsteroidal anti-inflammatory drug; eGFR, estimated glomerular filtration rate; LDH,
lactate dehydrogenase; gamma-GT; gamma-glutamyl transferase; CNI, calcineurin inhibitor.
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the notion that NaS1 worked at near maximal rates
under pre-donation conditions. The relatively smaller
reduction in FSR, compared to TSR, indicates that the
decrease in the amount of renal sulfate transporters
exceeds the decrease in sulfate supply (i.e., filtered sul-
fate load) to the kidney. The relatively lower reduction
in filtered load can likely be attributed to the
hyperfiltration of the remaining kidney, since mGFR
decreases by around 35% after kidney donation.
Regarding renal function, in RTR and kidney donors
both TSR and FSR were positively associated with renal
function, which is in line with previous findings in dogs
(Berglund and Lotspeich 1956). For sodium is has been
long recognized that the tubular sodium reabsorption is
Figure 3. Associations between plasma sulfate, tubular sulfate reabsorption, and fractional sulfate reabsorption in 251 kidney donors before
donation and in 671 renal transplant recipients. Tubular and fractional sulfate reabsorption were calculated with creatinine clearance. Tubular
sulfate reabsorption in kidney donors Peffect < 0.001; Pnonlineariry = 0.20; tubular sulfate reabsorption in RTR Peffect < 0.001; Pnonlineariry < 0.001;
fractional sulfate reabsorption in kidney donors Peffect = 0.05; Pnonlineariry = 0.13; fractional sulfate reabsorption in RTR Peffect = 0.01;
Pnonlineariry = 0.16.
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increased at increasing GFR and this is termed the
glomerulotubular balance (GTB) (Thomson and Blantz
2008). Though the mechanisms of the GTB aren’t fully
understood for sodium, it is possible a comparable effect
takes place for sulfate, which could explain the findings
for TSR. This, however, does not explain the positive
association of renal function with FSR.
Unfortunately, there are only a few other studies that
studied sulfate reabsorption in men. One of these, infused
sulfate in a small group of healthy young adults and
showed that the maximum tubular reabsorption of sulfate
is rapidly exceeded with increasing plasma sulfate levels.
Consequently, the amount of filtered sulfate becomes
greater than the amount reabsorbed in tubules (Becker
et al. 1960). Based on this, sulfate clearance should
asymptotically approach GFR at increasing filtered loads,
leading to a decreasing sulfate reabsorption coefficients.
Therefore, we expected to find an inverse association
between sulfate reabsorption and plasma sulfate. How-
ever, our data revealed the opposite, as we found a posi-
tive association between plasma sulfate and sulfate
reabsorption in our kidney donors and RTR. These find-
ings could indicate that, although sulfate reabsorption is
quickly saturated within individuals, in persons with
higher plasma sulfate concentrations at steady state, renal
sulfate reabsorption is increased, perhaps through upregu-
lation of the NaS1 transporter in these individuals. A
plausible physiological reason for up-regulation of sulfate
reabsorption could be an increased sulfate demand, possi-
bly due to increased exposure to drugs and endotoxins
that are frequently conjugated with sulfate before they are
excreted in urine (Levy 1986; Falany 1997). With reduced
renal function, retention of uremic toxins and drugs
increases (Meijers and Evenepoel 2011; Lekawanvijit
2015), which may increase the sulfate demand for sulfa-
tion of these compounds, as this process promotes renal
excretion through increased solubility. Though specula-
tive, an increase in sulfate reabsorption to meet the
increased sulfate supply is no unknown phenomenon, as
it also occurs during pregnancy, where plasma sulfate
levels increase more than twofold through upregulation of
the NaS1 transporter (Lind 1980; Dawson et al. 2015).
To further identify the determinants of FSR in RTR, we
analyzed hormonal and nonhormonal factors that were
shown to influence NaS1 gene transcription in animal and
in vitro studies. These factors included: dietary sulfate
Table 3. Regression analyses with potential determinants of fractional sulfate reabsorption in renal transplant recipients.
Potential determinants
Univariable models Multivariable model1
Stand. beta P-value Stand. beta P-value
Plasma sulfate, mmol/L 0.11 0.011 0.05 0.203
Urinary thiosulfate, lmol/24 h 0.23 <0.001 0.18 0.002
Creatinine cleanance (mL/min) 0.10 0.021 0.16 <0.001
Dietary intake
Alcohol intake, g/d 0.18 <0.001 0.14 0.002
Water intake, g/d 0.13 0.002 0.15 0.003
Bread intake, g/d 0.15 <0001 0.12 0.010
Daily fruit, g/d 0.08 0.056 0.12 0.005
Methionine, mg/d 0.17 <0.001 0.34 <0.001
Cysteine, mg/d 0.17 <0.001 0.41 <0.001
Vitamin D intake, lg/d 0.12 0.004 0.14 0.009
Cardiovascular
NSAID, n (%) 0.02 0.628 0.01 0.753
Serum potassium, mmol/L 0.04 0.356 0.04 0.322
Metabolic parameters
Venous pH 0.01 0.871 0.03 0.534
Venous HCO3
, mmol/L 0.03 0.533 0.02 0.631
Net acid Excretion, mEq/24 h 0.23 <0.001 0.19 <0.001
Endocrinology
Thyroxine pmol/L 0.05 0.239 0.07 0.086
Triiodothyronine, pmol/L 0.03 0.476 0.03 0.533
Growth hormone, ng/mL 0.14 0.001 0.11 0.007
In men 0.20 <0.001 0.21 <0.001
In women 0.05 0.475 0.04 0.599
FSR, fractional sulfate reabsorption; RTR, renal transplant recipients; NSAID, nonsteroidal anti-inflammatory drug.
1
Adjusted for potential confounders, including age, gender, smoking, BMI, proteinuria, total energy intake and primary renal disease.
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(Sabry et al. 1965; Neiberger 1991; Grimble 1994; Houter-
man et al. 1997; Markovich et al. 1998; Sagawa et al.
1998b), NSAID use (Sagawa et al. 1998a), acidosis (Frick
and Durasin 1986), Vitamin D depletion(Fernandes et al.
1997), hypothyroidism (Sagawa et al. 1999b), and hypoka-
lemia (Markovich et al. 1999), which down-regulated the
NaS1 transporter whereas sulfate depletion, hyperthy-
roidism (Tenenhouse et al. 1991), growth hormone
(Sagawa et al. 1999a) and vitamin D suppletion (Fernan-
des et al. 1997) up-regulated the NaS1 transporter. In
RTR, we confirmed dietary sulfate intake (methionine,
cysteine and sulfate-rich sources), growth hormone and
vitamin D intake as determinants for RSR. In addition, we
found an inverse association for thiosulfate excretion,
which is known to be a competitive inhibitor for sulfate
transport by NaS1. No associations were found for thyroid
hormones, serum pH, serum potassium and NSAID use.
It should be noted that in the RTR, the pH, potassium
and thyroid values were mostly within reference ranges
which could explain the discrepancy between our findings
and data from the aforementioned studies.
Strengths of this study include the large sample size of
this well-defined and specific patient group. The presence
of many demographical and laboratory parameters enables
adjustment for many potential confounders. In addition,
the information on many dietary and endocrine parame-
ters facilitated a comprehensive approach towards identifi-
cation of determinants of sulfate reabsorption in RTR.
However, several limitations of this study need to be
addressed. For most variables, our results were within the
reference range, precluding the assessment of states of
deficiencies or excess. Furthermore, we did not have infor-
mation on total direct sulfate intake. For direct sulfate
intake, we relied on certain foodstuffs (e.g., bread) that are
known to be high in sulfate content. A third limitation
involves the term determinants, in this study we spoke
about the determinants of sulfate reabsorption, since this
study tried to confirm the results seen in animal and
in vitro studies. However, since this is an observational
study design, we cannot draw conclusions on causality
and should technically speak about bidirectional associa-
tions. Additionally, since we did not have data regarding
the NaS1 transcription, we could not explore the molecu-
lar mechanisms underlying the observed associations.
Lastly, due to lack of statistical power, we were unable to
conduct the determinants analyses in the kidney donors.
In conclusion, RTR have higher plasma sulfate concen-
trations and lower TSR and FSR than kidney donors. In
kidney donors, kidney donation greatly reduced both TSR
and FSR and in both RTR and kidney donors, TSR and
FSR were associated with renal function. In addition, this
study confirms serum growth hormone, thiosulfate excre-
tion, vitamin D intake and dietary sulfate intake as
determinants for FSR in RTR. Future research should
determine the physiological mechanisms behind renal sul-
fate handling in humans and the prognostic value of renal
sulfate reabsorption in RTR
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